Literature DB >> 23431214

Measuring evidence-based practice in physical therapy: translation, adaptation, further development, validation, and reliability test of a questionnaire.

Susanne Bernhardsson1, Maria E H Larsson.   

Abstract

BACKGROUND: Evidence-based practice (EBP) and evidence-based clinical practice guidelines are becoming increasingly important in physical therapy. For the purpose of meeting the goals of designing, implementing, and evaluating strategies to facilitate the development of more EBP in primary care physical therapy, a valid and reliable questionnaire for measuring attitudes, knowledge, behavior, prerequisites, and barriers related to EBP and guidelines is needed.
OBJECTIVE: The 3 objectives of this study were: (1) to translate and cross-culturally adapt a questionnaire to a Swedish primary care context for the purpose of measuring various aspects of EBP and guidelines in physical therapy, (2) to further develop the questionnaire to examine more aspects of guidelines, and (3) to test the validity and reliability of the adapted Swedish questionnaire.
DESIGN: This was an instrument development study with validity and reliability testing.
METHODS: A previously used questionnaire about EBP was translated and cross-culturally adapted to a Swedish primary care physical therapy context. Additional items were constructed. A draft version was pilot tested for content validity (n=10), and a revised version was tested for test-retest reliability (n=42). The percentage of agreement between the 2 tests was analyzed.
RESULTS: The development process resulted in a first questionnaire draft containing 48 items. The validation process resulted in a second draft with acceptable content validity and consisting of 38 items. The test-retest analysis showed that the median percentage of agreement was 67% (range=41%-81%). After removal or revision of items with poor agreement, the final questionnaire included 31 items. LIMITATIONS: Only face validity and content validity were tested.
CONCLUSIONS: The final translated and adapted questionnaire was determined to have good face and content validity and acceptable reliability for measuring self-reported attitudes, knowledge, behavior, prerequisites, and barriers related to EBP and guidelines among physical therapists in primary care settings.

Mesh:

Year:  2013        PMID: 23431214     DOI: 10.2522/ptj.20120270

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  5 in total

1.  Knowledge, attitudes and use of evidence-based practice among midwives in Belgium: A cross-sectional survey.

Authors:  Dorien Lanssens; Régine Goemaes; Christine Vrielinck; Inge Tency
Journal:  Eur J Midwifery       Date:  2022-06-10

2.  Barriers against incorporating evidence-based practice in physical therapy in Colombia: current state and factors associated.

Authors:  Robinson Ramírez-Vélez; M Caridad Bagur-Calafat; Jorge Enrique Correa-Bautista; Montserrat Girabent-Farrés
Journal:  BMC Med Educ       Date:  2015-12-12       Impact factor: 2.463

3.  Evidence-Based Practice in Primary Care Occupational Therapy: A Cross-Sectional Survey in Sweden.

Authors:  Ann-Charlotte Lindström; Susanne Bernhardsson
Journal:  Occup Ther Int       Date:  2018-10-28       Impact factor: 1.448

4.  Evaluation of a tailored, multi-component intervention for implementation of evidence-based clinical practice guidelines in primary care physical therapy: a non-randomized controlled trial.

Authors:  Susanne Bernhardsson; Maria E H Larsson; Robert Eggertsen; Monika Fagevik Olsén; Kajsa Johansson; Per Nilsen; Lena Nordeman; Maurits van Tulder; Birgitta Öberg
Journal:  BMC Health Serv Res       Date:  2014-03-04       Impact factor: 2.655

5.  Validity and test retest reliability of the vascular quality of life Questionnaire-6: a short form of a disease-specific health-related quality of life instrument for patients with peripheral arterial disease.

Authors:  Christine Kumlien; Joakim Nordanstig; Mats Lundström; Monica Pettersson
Journal:  Health Qual Life Outcomes       Date:  2017-09-29       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.